Health X Platform updates website to healthxplatform.com

Health X Platform Limited has changed its corporate website address to https://www.healthxplatform.com , replacing the previous domain https://www.sastasundarventures.com with immediate effect. The company communicated this change to the stock exchanges on June 02, 2026, under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The transition follows the company's recent rebranding from Sastasundar Ventures Limited to Health X Platform Limited, which received stock exchange approval on April 25, 2026. Health X Platform Limited has requested BSE Limited and National Stock Exchange of India Limited to update the new website link in the Corporate Information Section on their respective portals.

Key Details

Detail	Information
Old Website	https://www.sastasundarventures.com
New Website	https://www.healthxplatform.com
Effective Date	June 02, 2026
Regulation	SEBI (LODR) Regulations, 2015

The intimation was signed by Pratap Singh, Company Secretary & Compliance Officer of Health X Platform Limited. The company is listed on BSE with scrip code 533259 and on NSE with the symbol HEALTHX.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+0.30%	-2.76%	+7.54%	-2.76%	+16.09%	+42.39%

Health X Platform Limited (formerly known as Sastasundar Ventures Limited) will engage with investors and analysts during a virtual meeting scheduled for June 12, 2026, at 4:00 P.M. IST. The company intends to discuss its performance and strategy to ensure stakeholders remain informed about its business operations.

The event will be conducted as a Group Conference via a virtual mode, requiring prior registration. Health X Platform noted that the schedule remains subject to change due to exigencies on the part of the analysts or investors.

Event Details

Event Name	Health X Platform Limited - Analyst Meet 2026
Meeting Type	Group Conference
Mode	Virtual
Timings	Friday, 12th June 2026, at 4:00 P.M. (IST)
Link to Register	Click here

The company explicitly stated that only information already available in the public domain will be shared or discussed during the interaction. It further clarified that no unpublished price sensitive information will be disclosed during the session.

This disclosure was submitted to BSE Limited and National Stock Exchange of India Limited in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation was signed by Pratap Singh, Company Secretary & Compliance Officer.